Skip to main content

GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain.

Publication ,  Journal Article
Amato, AA; Rajagopalan, S; Lin, JZ; Carvalho, BM; Figueira, ACM; Lu, J; Ayers, SD; Mottin, M; Silveira, RL; Souza, PCT; Mourão, RHV; Saad, MJA ...
Published in: The Journal of biological chemistry
August 2012

The recent discovery that peroxisome proliferator-activated receptor γ (PPARγ) targeted anti-diabetic drugs function by inhibiting Cdk5-mediated phosphorylation of the receptor has provided a new viewpoint to evaluate and perhaps develop improved insulin-sensitizing agents. Herein we report the development of a novel thiazolidinedione that retains similar anti-diabetic efficacy as rosiglitazone in mice yet does not elicit weight gain or edema, common side effects associated with full PPARγ activation. Further characterization of this compound shows GQ-16 to be an effective inhibitor of Cdk5-mediated phosphorylation of PPARγ. The structure of GQ-16 bound to PPARγ demonstrates that the compound utilizes a binding mode distinct from other reported PPARγ ligands, although it does share some structural features with other partial agonists, such as MRL-24 and PA-082, that have similarly been reported to dissociate insulin sensitization from weight gain. Hydrogen/deuterium exchange studies reveal that GQ-16 strongly stabilizes the β-sheet region of the receptor, presumably explaining the compound's efficacy in inhibiting Cdk5-mediated phosphorylation of Ser-273. Molecular dynamics simulations suggest that the partial agonist activity of GQ-16 results from the compound's weak ability to stabilize helix 12 in its active conformation. Our results suggest that the emerging model, whereby "ideal" PPARγ-based therapeutics stabilize the β-sheet/Ser-273 region and inhibit Cdk5-mediated phosphorylation while minimally invoking adipogenesis and classical agonism, is indeed a valid framework to develop improved PPARγ modulators that retain antidiabetic actions while minimizing untoward effects.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

The Journal of biological chemistry

DOI

EISSN

1083-351X

ISSN

0021-9258

Publication Date

August 2012

Volume

287

Issue

33

Start / End Page

28169 / 28179

Related Subject Headings

  • Weight Gain
  • U937 Cells
  • Thiazolidinediones
  • Protein Structure, Secondary
  • Phosphorylation
  • PPAR gamma
  • NIH 3T3 Cells
  • Mice
  • Ligands
  • Hypoglycemic Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Amato, A. A., Rajagopalan, S., Lin, J. Z., Carvalho, B. M., Figueira, A. C. M., Lu, J., … Neves, F. A. R. (2012). GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain. The Journal of Biological Chemistry, 287(33), 28169–28179. https://doi.org/10.1074/jbc.m111.332106
Amato, Angélica A., Senapathy Rajagopalan, Jean Z. Lin, Bruno M. Carvalho, Ana C. M. Figueira, Jenny Lu, Stephen D. Ayers, et al. “GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain.The Journal of Biological Chemistry 287, no. 33 (August 2012): 28169–79. https://doi.org/10.1074/jbc.m111.332106.
Amato AA, Rajagopalan S, Lin JZ, Carvalho BM, Figueira ACM, Lu J, et al. GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain. The Journal of biological chemistry. 2012 Aug;287(33):28169–79.
Amato, Angélica A., et al. “GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain.The Journal of Biological Chemistry, vol. 287, no. 33, Aug. 2012, pp. 28169–79. Epmc, doi:10.1074/jbc.m111.332106.
Amato AA, Rajagopalan S, Lin JZ, Carvalho BM, Figueira ACM, Lu J, Ayers SD, Mottin M, Silveira RL, Souza PCT, Mourão RHV, Saad MJA, Togashi M, Simeoni LA, Abdalla DSP, Skaf MS, Polikparpov I, Lima MCA, Galdino SL, Brennan RG, Baxter JD, Pitta IR, Webb P, Phillips KJ, Neves FAR. GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain. The Journal of biological chemistry. 2012 Aug;287(33):28169–28179.

Published In

The Journal of biological chemistry

DOI

EISSN

1083-351X

ISSN

0021-9258

Publication Date

August 2012

Volume

287

Issue

33

Start / End Page

28169 / 28179

Related Subject Headings

  • Weight Gain
  • U937 Cells
  • Thiazolidinediones
  • Protein Structure, Secondary
  • Phosphorylation
  • PPAR gamma
  • NIH 3T3 Cells
  • Mice
  • Ligands
  • Hypoglycemic Agents